Statin Therapy in Rheumatoid ArthritisA Cost-Effectiveness and Value-of-Information Analysis

被引：0
|
作者：
Nick Bansback
Roberta Ara
Sue Ward
Aslam Anis
Hyon K. Choi
机构：
[1] St Paul’s Hospital,Centre for Health Evaluation and Outcome Sciences
[2] University of Sheffield,School of Health and Related Research, Health Economics and Decision Sciences
[3] University of British Columbia,Department of Healthcare and Epidemiology
[4] University of British Columbia,Rheumatology Division, Department of Medicine, Arthritis Research Centre of Canada, Vancouver General Hospital
来源：
PharmacoEconomics | 2009年 / 27卷
关键词：
Rheumatoid Arthritis; Statin; Rheumatoid Arthritis Patient; Atorvastatin; Statin Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: HMG-CoA reductase inhibitors (statins) are potentially excellent candidate agents for patients with rheumatoid arthritis (RA). They reduce both cardiovascular risks and RA disease activity.
引用
收藏
页码：25 / 37
页数：12
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS, IN COLOMBIA
    Gamboa, O.
    Barbosa, D.
    Parada, L.
    Latorre, M.
    VALUE IN HEALTH, 2013, 16 (07) : A563 - A563
  • [32] Cost-effectiveness analysis of rituximab for rheumatoid arthritis in Taiwan
    Lou, S. F.
    Chen, D. Y.
    Cheng, T. T.
    Huang, C. M.
    Lin, H. Y.
    Su, C. C.
    Tsai, W. C.
    Tseng, J. C.
    Wei, C. C.
    Yang, L.
    Hazard, S.
    Chang, D. M.
    VALUE IN HEALTH, 2008, 11 (03) : A257 - A258
  • [33] Value-of-Information Analysis of a Fracture Prediction Method
    Almansour, Abdulaziz
    Laubach, Stephen E.
    Bickel, J. Eric
    Schultz, Richard A.
    SPE RESERVOIR EVALUATION & ENGINEERING, 2020, 23 (03) : 811 - 823
  • [34] COMBINATION DMARDS FOR RHEUMATOID ARTHRITIS: A COST-EFFECTIVENESS ANALYSIS
    Tosh, Jonathan
    Wailoo, Allan
    RHEUMATOLOGY, 2009, 48 : I68 - I69
  • [35] A cost-effectiveness analysis of biological treatments for rheumatoid arthritis
    Chiou, CF
    Wanke, L
    Yu, E
    Ofman, J
    VALUE IN HEALTH, 2004, 7 (03) : 223 - 223
  • [36] The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
    Wailoo, Allan
    Hock, Emma S.
    Stevenson, Matt
    Martyn-St James, Marrissa
    Rawdin, Andrew
    Simpson, Emma
    Wong, Ruth
    Dracup, Naila
    Scott, David L.
    Young, Adam
    HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (71) : 1 - +
  • [37] Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods
    Koerkamp, BG
    Hunink, MGM
    Stijnen, T
    Weinstein, MC
    HEALTH ECONOMICS, 2006, 15 (04) : 383 - 392
  • [38] Cost-effectiveness of C-reactive protein screening to target statin therapy
    Blake, GJ
    Ridker, PM
    Kuntz, KM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 440A - 440A
  • [39] The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction
    Ademi, Zanfina
    Ofori-Asenso, Richard
    Zomer, Ella
    Owen, Alice
    Liew, Danny
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (08) : 897 - 904
  • [40] MODELING ZIDOVUDINE THERAPY - A COST-EFFECTIVENESS ANALYSIS
    PALTIEL, AD
    KAPLAN, EH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (08): : 795 - 804
12345